Altre lingue Centogene N.V.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 13/06/2024			Variaz. 5gg	Var. 1 gen.
0,3725 ^USD	-0,67%		+2,90%	-68,96%

16/05	L'imminente serie di dati economici sostiene i fondi negoziati in borsa e i futures azionari prima della campanella di giovedì.	MT
16/05	I migliori guadagni del mercato premarket	MT

Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.	31/05
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	31/05
Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	16/05
Top Premarket Gainers	16/05
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K	15/05
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	15/05
Centogene N.V. Provides Earnings Guidance for the Year 2024	15/05
Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	15/05
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	15/05
Centogene N : Voting Proxy AGM 2024	15/05
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)	15/05
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment	14/05
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	14/05
Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease	14/05
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	13/05
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	10/05
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients	10/05
Centogene N : Form 6-K	02/05
Centogene Gets Nasdaq Noncompliance Notice	02/04
CENTOGENE Receives Nasdaq Non-Compliance Notice	02/04

Non ci sono risultati per questa ricerca